BRG.AU

26.68

-11.8%↓

LLC.AU

5.8

-1.36%↓

BRG.AU

26.68

-11.8%↓

LLC.AU

5.8

-1.36%↓

BRG.AU

26.68

-11.8%↓

LLC.AU

5.8

-1.36%↓

BRG.AU

26.68

-11.8%↓

LLC.AU

5.8

-1.36%↓

BRG.AU

26.68

-11.8%↓

LLC.AU

5.8

-1.36%↓

Search

Fisher & Paykel Healthcare Corp Ltd

Geschlossen

BrancheImmobilien

31.79 -1.46

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

31.19

Max

32.22

Schlüsselkennzahlen

By Trading Economics

Einkommen

153M

Verkäufe

951M

KGV

Branchendurchschnitt

148.143

80.437

EPS

0.26

Dividendenrendite

1.26

Gewinnspanne

16.106

Angestellte

6,978

EBITDA

276M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+20.89% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.26%

5.59%

Nächstes Ergebnis

28. Mai 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-3.8B

18B

Vorheriger Eröffnungskurs

33.25

Vorheriger Schlusskurs

31.79

Nachrichtenstimmung

By Acuity

82%

18%

180 / 192 Ranking in Real estate

Fisher & Paykel Healthcare Corp Ltd Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Feb. 2025, 21:55 UTC

Market Talk

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2. Feb. 2025, 22:06 UTC

Market Talk

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28. Nov. 2024, 21:55 UTC

Market Talk

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18. Nov. 2024, 22:39 UTC

Market Talk

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2. Sept. 2024, 23:56 UTC

Market Talk

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

30. Mai 2024, 00:44 UTC

Market Talk
Ergebnisse

Fisher & Paykel FY 2025 Guidance Hinges on Currency -- Market Talk

29. Mai 2024, 23:35 UTC

Market Talk

Fisher & Paykel to Benefit From FX Tailwinds -- Market Talk

28. Mai 2024, 22:43 UTC

Market Talk

Fisher & Paykel Healthcare Making Progress in Improving Margins -- Market Talk

28. Mai 2024, 20:59 UTC

Ergebnisse

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Net Profit After Tax NZ$310M to NZ$360M

28. Mai 2024, 20:58 UTC

Ergebnisse

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Rev NZD1.9B-NZD2B

28. Mai 2024, 20:57 UTC

Ergebnisse

Fisher & Paykel Healthcare Corp. Ltd. FY24 Net Profit After Tax NZ$132.6M

28. Mai 2024, 20:56 UTC

Ergebnisse

Fisher & Paykel Healthcare Corp. Ltd. FY24 Rev NZD1.742B

24. Apr. 2024, 02:38 UTC

Market Talk

F&P Healthcare's Prospects Brighten on Anaesthesia Opportunity -- Market Talk

Peer-Vergleich

Kursveränderung

Fisher & Paykel Healthcare Corp Ltd Prognose

Kursziel

By TipRanks

20.89% Vorteil

12-Monats-Prognose

Durchschnitt 37.453 AUD  20.89%

Hoch 42.7 AUD

Tief 35 AUD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Fisher & Paykel Healthcare Corp Ltd – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

6 ratings

3

Buy

1

Halten

2

Sell

Stimmung

By Acuity

180 / 192 Ranking in Immobilien

Nachrichtenstimmung

Sehr starke bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.